Compare Anterion Therapeutics vs Chiome Bioscience
Customers evaluate the quality of Anterion Therapeutics's products using the following success metrics.
Overview
Anterion Therapeutics is based in United States
Anterion Therapeutics inc is engaged in the research, development, preclincal and human clinical testing.
Chiome Bioscience is 19 yrs old and is based in Japan.
Chiome Bioscience (TYO:4583) leverages the ADLib System, a proprietary monoclonal antibody-generating technology for drug development. The company also provides drug discovery support. It creates lead antibody drugs, engages in the production of specific antibodies against antigens, and conducts research and development through the ADLib System. Chrome Bioscience was founded in 2005 and is based in Tokyo, Japan.
Demo Video
Investors
Richard Millian
Fast Track Initiative and SMBC Venture Capital
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Anterion Therapeutics has not claimed their profile.
Work for Anterion Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Anterion Therapeutics?
Claim your profile now.
Information not available because Chiome Bioscience has not claimed their profile.
Work for Chiome Bioscience? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Chiome Bioscience?
Claim your profile now.